Publish in this journal
Journal Information
Vol. 10. Issue 4.
Pages 268-269 (July - August 2014)
Vol. 10. Issue 4.
Pages 268-269 (July - August 2014)
Letter to the Editor
Full text access
Usefulness of the Ankle-brachial Index as a Survey Method for Subclinical Vascular Disease in Patients With Rheumatoid Arthritis
Utilidad del índice tobillo-brazo como método de cribado de enfermedad vascular subclínica en pacientes con artritis reumatoide
Visits
...
Cristina Marcos de Frutos, Daniel Abad Pérez
Corresponding author
danielabadperez@hotmail.com

Corresponding author.
, Carmen Suárez Fernández
Servicio de Medicina Interna, Hospital Universitario de La Princesa, Madrid, Spain
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Full Text
To the Editor,

Rheumatoid arthritis (RA) is a systemic inflammatory disease, with a chronic and variable evolution, characterized by persistent and symmetrical synovitis of the peripheral joints. In recent years its natural history has changed thanks to advances in treatment, so comorbidities have become more important; in fact, increased mortality compared to the general population is primarily a result of diseases of cardiovascular origin,1 with rates up to 50% or higher.

In RA underlying atherosclerotic disease is increased2 secondary to chronic inflammation, which involves activation of T lymphocytes and macrophages, production of proinflammatory cytokines3 (gamma interferon, tumor necrosis factor, IL-1 and IL-6). It is potentiated due to classic cardiovascular risk factors (CVRF), including the metabolic syndrome, which is more prevalent probably due to less physical activity because of joint pain and moreover, dyslipidemia follows a more atherogenic4 pattern.

With all these data, we conclude that the RA is a situation with a high CVR, where cardiovascular morbidity is related to the disease activity, so its control could reduce the risk.5 Therefore, this study proposes to detect subclinical CVD by measuring the ankle-brachial index (ABI).

We performed a descriptive cross-sectional study on 60 RA patients with no history of CVD, at the University Hospital of La Princesa, Madrid, selected consecutively in the rheumatology clinic during the 6 months when the study was carried out. Sociodemographic variables, analytical data, classic CVRF, duration of RA and immunomodulatory treatment were collected. ABI was defined as abnormal if less than 0.9.6

Of the 60 patients enrolled, 3 were men (5%) and 57 women (95%) with a mean age±standard deviation of 53.75 years (53.75±15.38, range 29–87). 38 had mild RA (63.3%), while 22 (36.7%) had important deformities. The time of disease progression was 9.14 years (9.14±6.505, range 0.6–40), 58 patients (96.7%) were under immunomodulatory therapy, mostly with methotrexate (75%). The result of the ABI was similar in both lower limbs: 1.074 (1.074±0.082, range 0.88–1.28) on the right and 1.077 (1.077±0.088, range 0.92–1.27) on the left, with no significant differences between them. Only one patient (1.7%) had an abnormal ABI: a woman of 87 years, with hypertension, and RA for 12 years and using corticosteroids during virtually all this time; the ABI on the other extremity was 0.92. Fig. 1 shows the ABI results.

Fig. 1.

Results of the ABI on the left and right lower extremities.

(0.18MB).

In our sample, there is an overrepresentation of women (19:1) with respect to other RA populations (3:1). However, the profile of CVR did not differ regarding the Spanish general population.7 Only one pathological case was detected, much lower than other studies,8,9 with rates of 20%–25%, although the frequency cutoff point considered as pathological was 1, rather than the value of 0.9 currently accepted. However, in another publication with the same cutoff,10 the prevalence was 10%, although in their sample the mean age, duration of RA and, above all, the prevalence of cardiovascular risk factors (especially diabetes and dyslipidemia) were superior. Other possible factors involved could be the adequate control of the disease, since only 3.3% of patients had no specific treatment and the value of the acute phase reactants was normal.

A major limitation to the study was accessibility, as the ABI was performed after the patient visit, so many of the patients excluded were those who refused to participate, claiming physical difficulty to go and get tested, which may have been a selection bias, having lost the sickest patients.

In conclusion, based on our results we do not consider routine ABI testing justified in asymptomatic patients with RA from a cardiovascular point of view.

References
[1]
H. Maradit-Kremers, P.J. Nicola, C.S. Crowson, K.V. Ballman, S.E. Gabriel.
Cardiovascular death in rheumatoid arthritis: a population-based study.
Arthritis Rheum, 52 (2005), pp. 722-732
[2]
M.A. Gonzalez-Gay, C. Gonzalez-Juanatey, J. Martin.
Rheumatoid arthritis: a disease associated with accelerated atherogenesis.
Semin Arthritis Rheum, 35 (2005), pp. 8-17
[3]
E. Galkina, K. Ley.
Immune and inflammatory mechanisms of atherosclerosis.
Annu Rev Immunol, 27 (2009), pp. 165-197
[4]
E. Hurt-Camejo, S. Paredes, L. Masana, G. Camejo, P. Sartipy, B. Rosengren, et al.
Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: possible contribution of phospholipase A2 to this atherogenic profile.
Arthritis Rheum, 44 (2001), pp. 2761-2767
[5]
S.E. Gabriel.
Cardiovascular morbidity and mortality in rheumatoid arthritis.
Am J Med, 121 (2008), pp. S9-S14
[6]
A.T. Hirsch, Z.J. Haskal, N.R. Hertzer, C.W. Bakal, M.A. Creager, J.L. Halperin, et al.
ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.
Circulation, 113 (2006), pp. e463-e654
[7]
M. Grau, R. Elosua, A. Cabrera de León, M.J. Guembe, J.M. Baena-Díez, T. Vega Alonso, et al.
Factores de riesgo cardiovascular en España en la primera década del siglo xxi: análisis agrupado con datos individuales de 11 estudios de base poblacional, estudio DARIOS.
Rev Esp Cardiol, 64 (2011), pp. 295-304
[8]
J.K. Alkaabi, M. Ho, R. Levison, T. Pullar, J.J. Belch.
Rheumatoid arthritis and macrovascular disease.
Rheumatology, 42 (2003), pp. 292-297
[9]
S.M. Rachapalli, P.D. Kiely, B.E. Bourke.
Prevalence of abnormal ankle brachial index in patients with primary Sjogren's syndrome.
Clin Rheumatol, 28 (2009), pp. 587-590
[10]
I. Del Rincon, R.W. Haas, S. Pogosian, A. Escalante.
Lower limb arterial incompressibility and obstruction in rheumatoid arthritis.
Ann Rheum Dis, 64 (2005), pp. 425-432

Please cite this article as: Marcos de Frutos C, Abad Pérez D, Suárez Fernández C. Utilidad del índice tobillo-brazo como método de cribado de enfermedad vascular subclínica en pacientes con artritis reumatoide. Reumatol Clin. 2014;10:268–269.

Copyright © 2013. Elsevier España, S.L.. All rights reserved
Idiomas
Reumatología Clínica (English Edition)

Subscribe to our newsletter

Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?